Wikipedia's first sentence called it “israeli academic and researcher working in ophthalmology”. Today it says “israeli academic researcher and inventor”. The one-line description Wikipedia serves to search engines and AI systems read “Israeli ophthalmology professor”. It now reads “Israeli ophthalmology professor Prof”.
Measured, not asserted. Every count, date and revision on this page was taken from Wikipedia's own history and checked against the live article. The words quoted are theirs.
Machine-checked against the full current article on 2026-08-03.
We saved snapshots of this article over twenty years; you are reading the 2025 one. Red dashes: removed from Wikipedia since.Pale dots: rewritten; the numbered note shows what it says now.Red text: written in or rewritten since the previous snapshot.1 tap a number or a side note to jump between them
The opening as it read in 2025
Michael Belkin Michael Belkin ( Hebrew : מיכאל בלקין) is an Israeli academic researcher and inventor. He is a Professor Emeritus of Ophthalmology at Tel-Aviv University , listed in the Ophthalmologists Power List for 2023 and 2024. His research and inventions brought about advances in treatment of eye diseases such as the ExPRESS glaucoma implant, Direct Selective Laser Trabeculoplasty (DSLT), an automatic, fast, non-contact glaucoma treatment, and CureSight, a binocular treatment of amblyopia . All three devices were approved by both the US FDA and European authorities. Professor Belkin established and was the inaugural director of the Tel-Aviv University Eye Research Institute at the Sheba Medical Center , and was among the founders of the Israel Society for Vision & Eye Research, as well as its second president. "ראה את זה מגיע | כלכליסט" . calcalist (in Hebrew). 2025-05-29 . "Long term effects of a stainless steel glaucoma implant ExPRESS in combined surgery with phacoemulsification" . Michael Belkin, an eye doctor with uncommon vision" . Michael Belkin Emeritus in Eye Imstitute (Goldschleger)" .
This is Wikipedia's own text, saved in our repository. Their copy of it is revision 1298057542.
The opening as it stood on October 6, 2023
Israeli ophthalmology professor Michael Belkin is an Israeli academic and researcher working in ophthalmology , Professor Emeritus of Ophthalmology at Tel Aviv University . His research brought about advances in glaucoma treatment such as the ExPress glaucoma implant, the Ioptimate CO 2 laser glaucoma surgery and a fast, non-contact glaucoma laser treatment. He established and was the inaugural director of the Tel Aviv University Eye Research Institute, located at the Sheba Medical Center. "Long term effects of a stainless steel glaucoma implant ExPRESS in combined surgery with phacoemulsification" . Michael Belkin, an eye doctor with uncommon vision" . Michael Belkin Emeritus in Eye Imstitute (Goldschleger)" .
Red text was written in or rewritten since the previous snapshot. Their copy is revision 1177364316.
Today
Wikipedia's first sentence called it “israeli academic and researcher working in ophthalmology”. Today it says “israeli academic researcher and inventor”. The one-line description Wikipedia serves to search engines and AI systems read “Israeli ophthalmology professor”. It now reads “Israeli ophthalmology professor Prof”. Read the current article and compare.
Oct '23
2025
Counts in the opening at each snapshot. Green: the word gained ground. Red: it was cut. Grey: no change.
What Wikipedia says this is
Every article opens by defining its subject. This one was redefined since 2023, and today's defining sentence is their current revision.
Then
israeli academic and researcher working in ophthalmology
Now
israeli academic researcher and inventor
Struck red text is no longer in the article; dotted amber text was rewritten. Every revision id links to Wikipedia's copy; the text shown is our own saved copy. Data: /data. Wikipedia text is CC BY-SA; quoted for the record; not affiliated with Wikipedia.
